This Week In Wellness phase 3 trials of a coronavirus vaccine being developed by AstraZeneca in conjunction with Oxford University have been suspended after an “unexplained illness”. The potential vaccine, which Australia has already secured 33.8 million doses of, has had it’s trials paused in order to allow for a review by an independent committee. Australia has also locked in 51 million doses of a potential vaccine being developed by the University of Queensland and CSL meaning that with those two commitments alone they will have access to a number of vaccines more than triple the Australian population.
Get personally mentored by me for FREE for 30 days head to www.exercisingresilience.com